Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
144,665,764
-
Shares change
-
-3,246,537
-
Total reported value, excl. options
-
$2,670,486,249
-
Value change
-
-$61,027,521
-
Put/Call ratio
-
81%
-
Number of buys
-
64
-
Number of sells
-
-66
-
Price
-
$18.46
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q3 2018
182 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q3 2018.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144,665,764 shares
of 161,976,581 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (19,433,137 shares), FMR LLC (16,914,985 shares), Vanguard Group Inc (12,324,954 shares), BlackRock Inc. (12,198,644 shares), PRICE T ROWE ASSOCIATES INC /MD/ (8,923,985 shares), JANUS HENDERSON GROUP PLC (7,986,775 shares), BROWN CAPITAL MANAGEMENT LLC (6,449,511 shares), UBS ASSET MANAGEMENT AMERICAS INC (6,188,599 shares), STATE STREET CORP (5,420,669 shares), and EcoR1 Capital, LLC (5,141,624 shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.